Latest Breaking News On - சிஐசி ஒன்றுபட்டது மாநிலங்களில் இன்க் - Page 2 : comparemela.com

Share this article Share this article ORLANDO, Fla., May 4, 2021 /PRNewswire/  Cabenuva (cabotegravir/rilpivrine), the first and only once-monthly complete injectable treatment is available through AllianceRx Walgreens Prime for adults living with human immunodeficiency virus type 1 (HIV-1). Manufactured for ViiV Healthcare by GlaxoSmithKline, Cabenuva provides an alternative to patients who relied on a daily oral treatment regimen. HIV is a virus that attacks the body s immune system. If not treated, it can lead to acquired immunodeficiency syndrome (AIDS). 1 HIV-1 is the predominant type of HIV worldwide, making up 95 percent of all HIV cases worldwide. 2 Cabenuva a complete regimen for the treatment of HIV-1 infection in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

Tracey jamesAdrienne foleyChiesi united states incAlliancerx walgreens primeViiv healthcareAlliancerx walgreensChiesi united statesBronchitol tolerance testPrime therapeuticsHealth care amp hospitalsMedical pharmaceuticalsNew products amp servicesட்ரேசி ஜேம்ஸ்சிஐசி ஒன்றுபட்டது மாநிலங்களில் இன்க்அள்ளிஅன்சர்ஸ் வால்க்ரீன்ஸ் ப்ரைம்அள்ளிஅன்சர்ஸ் வால்க்ரீன்ஸ்